• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对市售腺相关病毒(AAV)报告载体和质粒中的DNA点突变进行定量分析。

Quantifying DNA point mutations in commercially available AAV reporter vectors and plasmids.

作者信息

Rose Rebecca, Nolan David J, DaRoza Jonathan A, Boye Sanford L, Lamers Susanna L

机构信息

BioInfoExperts, Alachua, FL 32615, USA.

University of Florida Powell Gene Therapy Center, Gainesville, FL 32605, USA.

出版信息

Mol Ther Methods Clin Dev. 2025 Jun 2;33(3):101501. doi: 10.1016/j.omtm.2025.101501. eCollection 2025 Sep 11.

DOI:10.1016/j.omtm.2025.101501
PMID:40584571
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12206035/
Abstract

To compare the accuracy of three sequencing methods for quantifying point mutations in AAV products, we sequenced the green fluorescent protein (GFP) transgene from two AAV9 reporter vectors (three lots each) and their respective plasmids, using three sequencing approaches: single-template amplification (STA) followed by Sanger sequencing (STA-Sanger) and two next-generation sequencing (NGS) platforms (Illumina and Oxford Nanopore Technologies [ONT]). Similar vector per-base mutation rates were found for both STA-Sanger (0.016%) and Illumina (0.013%), with slightly lower rates in plasmid sequences (STA-Sanger: 0.0019%; Illumina: 0.0074%), whereas ONT per-base mutation rates were much higher (vector: 2.2%; plasmid: 1.3%). The non-reference majority variant frequency (MVF) was more strongly correlated among vector lots for ONT (R = 0.91) compared with Illumina (R = 0.46), although correlation between plasmid and vectors was similar for both platforms (R = 0.23) and virtually non-existent between platforms for the same sample (R < 0.05). Overall, our results showed evidence for single-nucleotide mutations in AAV products, although there was a lack of consistency among sequencing platforms, which underscores the need for the AAV industry to develop sequencing methodologies with improved accuracy as a standard QC protocol.

摘要

为了比较三种测序方法在定量腺相关病毒(AAV)产品点突变方面的准确性,我们使用三种测序方法对来自两个AAV9报告载体(各三批)及其各自质粒的绿色荧光蛋白(GFP)转基因进行了测序:单模板扩增(STA)后进行桑格测序(STA-桑格)以及两种新一代测序(NGS)平台(Illumina和牛津纳米孔技术公司[ONT])。STA-桑格测序(0.016%)和Illumina测序(0.013%)在载体上发现的每碱基突变率相似,质粒序列中的突变率略低(STA-桑格测序:0.0019%;Illumina测序:0.0074%),而ONT的每碱基突变率则高得多(载体:2.2%;质粒:1.3%)。与Illumina测序(R = 0.46)相比,ONT测序在载体批次之间的非参考多数变体频率(MVF)相关性更强(R = 0.91),尽管两个平台上质粒与载体之间的相关性相似(R = 0.23),并且同一样本在不同平台之间几乎不存在相关性(R < 0.05)。总体而言,我们的结果显示了AAV产品中存在单核苷酸突变的证据,尽管测序平台之间缺乏一致性,这突出表明AAV行业需要开发准确性更高的测序方法作为标准质量控制方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1f3/12206035/44ea98d381bf/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1f3/12206035/051ead170d67/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1f3/12206035/addd8056a607/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1f3/12206035/44ea98d381bf/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1f3/12206035/051ead170d67/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1f3/12206035/addd8056a607/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1f3/12206035/44ea98d381bf/gr2.jpg

相似文献

1
Quantifying DNA point mutations in commercially available AAV reporter vectors and plasmids.对市售腺相关病毒(AAV)报告载体和质粒中的DNA点突变进行定量分析。
Mol Ther Methods Clin Dev. 2025 Jun 2;33(3):101501. doi: 10.1016/j.omtm.2025.101501. eCollection 2025 Sep 11.
2
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
3
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
4
Comparison of Illumina and Oxford Nanopore Technology systems for the genomic characterization of .用于……基因组特征分析的Illumina和牛津纳米孔技术系统的比较
Microbiol Spectr. 2025 Jul;13(7):e0129424. doi: 10.1128/spectrum.01294-24. Epub 2025 May 28.
5
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
6
Maternal and neonatal outcomes of elective induction of labor.择期引产的母婴结局
Evid Rep Technol Assess (Full Rep). 2009 Mar(176):1-257.
7
Surgical interventions for treating extracapsular hip fractures in older adults: a network meta-analysis.老年人髋关节囊外骨折的手术干预:一项网络荟萃分析。
Cochrane Database Syst Rev. 2022 Feb 10;2(2):CD013405. doi: 10.1002/14651858.CD013405.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.未治疗的霍奇金淋巴瘤患者化疗和放疗在第二原发性恶性肿瘤、总生存期和无进展生存期方面的优化:个体参与者数据分析
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2.

本文引用的文献

1
Recombinant AAV batch profiling by nanopore sequencing elucidates product-related DNA impurities and vector genome length distribution.通过纳米孔测序对重组腺相关病毒批次进行分析,可阐明与产品相关的DNA杂质和载体基因组长度分布。
Mol Ther Methods Clin Dev. 2025 Jan 22;33(1):101417. doi: 10.1016/j.omtm.2025.101417. eCollection 2025 Mar 13.
2
Sequencing accuracy and systematic errors of nanopore direct RNA sequencing.纳米孔直接 RNA 测序的测序准确性和系统误差。
BMC Genomics. 2024 May 28;25(1):528. doi: 10.1186/s12864-024-10440-w.
3
The menace of severe adverse events and deaths associated with viral gene therapy and its potential solution.
病毒基因治疗相关的严重不良事件和死亡的威胁及其潜在解决方案。
Med Res Rev. 2024 Sep;44(5):2112-2193. doi: 10.1002/med.22036. Epub 2024 Mar 28.
4
Thorough molecular configuration analysis of noncanonical AAV genomes in AAV vector preparations.对腺相关病毒(AAV)载体制剂中非典型AAV基因组进行全面的分子构型分析。
Mol Ther Methods Clin Dev. 2024 Feb 19;32(1):101215. doi: 10.1016/j.omtm.2024.101215. eCollection 2024 Mar 14.
5
Stowaways in the cargo: Contaminating nucleic acids in rAAV preparations for gene therapy.货舱偷渡者:基因治疗用 rAAV 制剂中的污染核酸。
Mol Ther. 2023 Oct 4;31(10):2826-2838. doi: 10.1016/j.ymthe.2023.07.025. Epub 2023 Aug 2.
6
Strategies for improving detection of circulating tumor DNA using next generation sequencing.使用下一代测序技术提高循环肿瘤DNA检测的策略。
Cancer Treat Rev. 2023 Sep;119:102595. doi: 10.1016/j.ctrv.2023.102595. Epub 2023 Jun 25.
7
Best Practices in Designing, Sequencing, and Identifying Random DNA Barcodes.设计、测序和鉴定随机 DNA 条码的最佳实践。
J Mol Evol. 2023 Jun;91(3):263-280. doi: 10.1007/s00239-022-10083-z. Epub 2023 Jan 18.
8
Cryptic resolution sites in the vector plasmid lead to the heterogeneities in the rAAV vectors.载体质粒中的隐匿性解决位点导致 rAAV 载体的异质性。
J Med Virol. 2023 Jan;95(1):e28433. doi: 10.1002/jmv.28433.
9
DNA read count calibration for single-molecule, long-read sequencing.用于单分子、长读测序的 DNA 读取计数校准。
Sci Rep. 2022 Nov 1;12(1):17257. doi: 10.1038/s41598-022-21606-5.
10
Direct ITR-to-ITR Nanopore Sequencing of AAV Vector Genomes.直接将 ITR 到 ITR 纳米孔测序的 AAV 载体基因组。
Hum Gene Ther. 2022 Nov;33(21-22):1187-1196. doi: 10.1089/hum.2022.143.